Citi Upgrades Luye Pharma to Buy From Sell; Price Target Is HK$4
MT NewswiresAug 30 03:22 ET
Morgan Stanley Upgrades Gushengtang Holdings to Overweight From Equal-weight; Price Target Is HK$62
MT NewswiresJul 8 03:30 ET